Bessemer Group Inc Biotechnology

Bessemer Group Inc

$60.7 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
GERN Geron Corp	$1.08B	$3,000 0.0% of portfolio	565	Q3 2024 New
HRTX Heron Therapeutics, Inc.	$202M	$3,000 0.0% of portfolio	1,425	Q3 2024 New
KYMR Kymera Therapeutics, Inc.	$2.17B	$3,000 0.0% of portfolio	65	Q3 2024 New
NUVL Nuvalent, Inc.	$3.69B	$3,000 0.0% of portfolio	25	Q3 2024 New
PTCT Ptc Therapeutics, Inc.	$3.28B	$3,000 0.0% of portfolio	85	Q3 2024 New
SMMT Summit Therapeutics Inc.	$4.42B	$3,000 0.0% of portfolio	145	Q3 2024 New
TGTX Tg Therapeutics, Inc.	$4.61B	$3,000 0.0% of portfolio	137	Q3 2024 New
XNCR Xencor Inc	$1.09B	$3,000 0.0% of portfolio	130	Q3 2024 New
AKRO Akero Therapeutics, Inc.	$2.51B	$2,000 0.0% of portfolio	60	Q3 2024 New
ALT Altimmune, Inc.	$326M	$2,000 0.0% of portfolio	380	Q3 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$2.1B	$2,000 0.0% of portfolio	100	Q3 2024 Reduced 17.36%
AUPH Aurinia Pharmaceuticals Inc.	$1.13B	$2,000 0.0% of portfolio	215	Q3 2024 New
CDMO Avid Bioservices, Inc.	$776M	$2,000 0.0% of portfolio	160	Q3 2024 New
SAVA Cassava Sciences Inc	$95.4M	$2,000 0.0% of portfolio	55	Q3 2024 New
CLDX Celldex Therapeutics, Inc.	$1.15B	$2,000 0.0% of portfolio	60	Q3 2024 New
COGT Cogent Biosciences, Inc.	$612M	$2,000 0.0% of portfolio	180	Q3 2024 New
CGEM Cullinan Oncology, Inc.	$482M	$2,000 0.0% of portfolio	105	Q3 2024 New
DYN Dyne Therapeutics, Inc.	$736M	$2,000 0.0% of portfolio	60	Q3 2024 New
IDYA Ideaya Biosciences, Inc.	$1.17B	$2,000 0.0% of portfolio	50	Q3 2024 New
IOVA Iovance Biotherapeutics, Inc.	$923M	$2,000 0.0% of portfolio	175	Q3 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.73B	$2,000 0.0% of portfolio	10	Q3 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.31B	$2,000 0.0% of portfolio	30	Q3 2024 New
TERN Terns Pharmaceuticals, Inc.	$177M	$2,000 0.0% of portfolio	185	Q3 2024 New
TVTX Travere Therapeutics, Inc.	$1.31B	$2,000 0.0% of portfolio	165	Q3 2024 Reduced 50.6%
VERA Vera Therapeutics, Inc.	$1.01B	$2,000 0.0% of portfolio	35	Q3 2024 New
VRDN Viridian Therapeutics, Inc.\De	$795M	$2,000 0.0% of portfolio	85	Q3 2024 New
YMAB Y M Abs Therapeutics, Inc.	$261M	$2,000 0.0% of portfolio	180	Q3 2024 New
ETNB 89bio, Inc.	$450M	$1,000 0.0% of portfolio	130	Q3 2024 New
ACAD Acadia Pharmaceuticals Inc	$3.02B	$1,000 0.0% of portfolio	75	Q3 2024 New
RCUS Arcus Biosciences, Inc.	$931M	$1,000 0.0% of portfolio	70	Q3 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$797M	$1,000 0.0% of portfolio	110	Q3 2024 Reduced 69.44%
ARVN Arvinas, Inc.	$937M	$1,000 0.0% of portfolio	40	Q3 2024 Reduced 87.92%
BEAM Beam Therapeutics Inc.	$1.82B	$1,000 0.0% of portfolio	35	Q3 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.47B	$1,000 0.0% of portfolio	195	Q3 2024 Reduced 73.65%
DAWN Day One Biopharmaceuticals, Inc.	$909M	$1,000 0.0% of portfolio	85	Q3 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$274M	$1,000 0.0% of portfolio	90	Q3 2024 New
HUMA Humacyte, Inc.	$472M	$1,000 0.0% of portfolio	145	Q3 2024 New
IMVT Immunovant, Inc.	$3.55B	$1,000 0.0% of portfolio	50	Q3 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$217M	$1,000 0.0% of portfolio	45	Q3 2024 New
KROS Keros Therapeutics, Inc.	$294M	$1,000 0.0% of portfolio	25	Q3 2024 New
LQDA Liquidia Corp	$940M	$1,000 0.0% of portfolio	85	Q3 2024 New
LBPH Longboard Pharmaceuticals, Inc.	$815M	$1,000 0.0% of portfolio	30	Q3 2024 New
MNKD Mannkind Corp	$1.49B	$1,000 0.0% of portfolio	200	Q3 2024 New
MDXG Mimedx Group, Inc.	$988M	$1,000 0.0% of portfolio	160	Q3 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.8B	$1,000 0.0% of portfolio	30	Q3 2024 New
NVAX Novavax Inc	$680M	$1,000 0.0% of portfolio	70	Q3 2024 New
OCUL Ocular Therapeutix, Inc	$593M	$1,000 0.0% of portfolio	160	Q3 2024 New
ORIC Oric Pharmaceuticals, Inc.	$412M	$1,000 0.0% of portfolio	120	Q3 2024 New
PSTX Poseida Therapeutics, Inc.	$815M	$1,000 0.0% of portfolio	425	Q3 2024 New
PRTA Prothena Corp Public LTD CO	$668M	$1,000 0.0% of portfolio	55	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.